FREE Membership Sign in

Pharmaceutical treatments lacking

By Denis Méthot | January 22 2020 02:39PM

The term "orphan" appeared in the early 1980s in the United States in connection with the treatment of rare diseases. It was said that a disease was orphaned if there was no treatment other than that of its symptoms.

This article is reserved to PRO Level subscribers

Read the whole article….

PRO

$9.95 / month

Invest in your career and go PRO now!:

Each of its 6 annual issues offers you:

Exclusive headlines and daily scoops
Disciplinary decision news
On the move in the industry

Receive the Insurance Journal at your office or home:

6 issues/year
In-depth articles and studies related to the insurance industry
Insighful data to feed your analysis and convince your clients
Exclusive interviews with industry leaders

Rare and orphan diseases: a challenge for individuals and society

Pharmaceutical treatments lacking

Related to the same topic …

Flash

Jean-François Chalifoux unveils management team

Ignoring suitability lands representative with fine and five-year ban

Agent sanctioned by IIROC and the MFDA

Advocis announces appointments

Living Benefits

COVID-19: actuaries seek more robust data

UV Insurance introduces a distance selling solution for advisors

Non cancellable disability insurance comparative table

Non guaranteed disability insurance comparative table

Critical Illness

La Capitale provides free COVID-19 hospitalization benefit to CII clients

Canada Protection Plan expands CI insurance lineup

CHES announces new life insurance affiliate

Rare and orphan diseases: a challenge for individuals and society

Supplementary health insurance

Green Shield Canada offers pain management app to plan members

Canadians travel patterns expected to change post lockdown

COVID-19: Life insurers’ measures

Travel insurers will continue to provide individual health insurance for truckers

Drug insurance

CLHIA asks for strategies on expensive drugs and retirement plans

Pharmacare plan for Canadians still a question mark

Pharmaceutical company advocates for more accessible healthcare

Biosimilars: British Columbia extends transition program

Group Insurance

Should more insurers be providing fertility coverage?

Group insurance in the COVID-19 era

Hub International acquires Calgary-based firm

Hub acquires Toronto-based insurance brokerage

Drug Insurance

Canada Life aims to eliminate plastic drug cards

Advocate sounds alarm about the future availability of new medicines in Canada

Investing in mental health yields significant returns

SSQ offers pharmacogenetic testing to group plan members

Life Insurance

Franklin Templeton Canada to terminate ETF

The life insurance industry faces COVID-19

Solvency positions of DB plans rebound

Sun Life completes acquisition of InfraRed Capital Partners

Medication

COVID-19: Use of mental health medications on the rise

Venture market in Canada restyled

Lessons in group insurance from COVID-19

Consultation launched on draft pricing guidelines for patented medicines

Special Report

Sharp drop in dental care and extended care claims

Seniors’ worries go beyond the financial

Elderly Canadians suffering under financial impact of COVID-19

Financial advisors are playing a key role in helping seniors deal with pandemic